Increased glucose variability is associated with atrial fibrillation after coronary artery bypass

Kathleen C Clement1, Diane Alejo1, Joseph DiNatale1

  • 1Department of Surgery, Division of Cardiac Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Insights

Postoperative glucose variability and high mean glucose levels after coronary artery bypass grafting (CABG) increase the risk of atrial fibrillation. Preoperative hemoglobin A1c (HbA1c) is not a significant predictor after accounting for these factors.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Syndrome

Background:

  • Elevated preoperative hemoglobin A1c (HbA1c) predicts poor outcomes in coronary artery bypass grafting (CABG).
  • The impact of postoperative glucose variability (GV) on outcomes after CABG remains unclear.
  • This study investigates the association between short-term postoperative GV and atrial fibrillation risk.

Purpose of the Study:

  • To determine if short-term postoperative glucose variability (GV) is an independent predictor of postoperative atrial fibrillation (POAF) after isolated CABG.
  • To assess the relationship between mean glucose levels in the first 24 hours post-CABG and POAF.
  • To evaluate the predictive value of preoperative HbA1c for POAF in the context of postoperative glucose control.

Main Methods:

  • Retrospective analysis of 2073 patients undergoing isolated CABG (January 2012-March 2018).
  • Measurement of postoperative GV within the first 24 hours using standard deviation, coefficient of variation, and mean amplitude of glycemic excursions.
  • Multivariate logistic regression models were employed to identify independent predictors of POAF.

Main Results:

  • Postoperative atrial fibrillation (POAF) occurred in 446 patients (21.5%).
  • Increased 24-hour GV was significantly associated with a higher risk of POAF (OR=1.16, P<0.01).
  • Elevated 24-hour mean glucose also independently predicted POAF (OR=1.14, P<0.01), with a 16% and 14% increased risk for every 10% GV and 10 mg/dL mean glucose increase, respectively.

Conclusions:

  • Increased 24-hour glucose variability and mean glucose are significant predictors of atrial fibrillation following CABG.
  • Preoperative HbA1c did not predict POAF when postoperative glucose metrics were considered.
  • Further research is warranted to explore strict glucose control strategies to mitigate adverse events post-CABG.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
934
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.7K
Amyloid Fibrils03:03

Amyloid Fibrils

6.4K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
400
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
230
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
351